Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kole T Roybal

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Science Signaling|July 29, 2010
Inhibiting the inhibitor of the inhibitor: blocking PKC-theta to enhance regulatory T cell functionKole T Roybal, Christoph Wülfing
Trends in Cancer|November 11, 2019
Paving New Roads for CARsAxel Hyrenius-Wittsten, Kole T Roybal
Annual Review of Immunology|April 28, 2017
Synthetic Immunology: Hacking Immune Cells to Expand Their Therapeutic CapabilitiesKole T Roybal, Wendell A Lim
Communicative & Integrative Biology|February 19, 2011
Tentative and transient natural killer cell polarization balances the requirements for discriminatory recognition and cytolytic efficacyParisa Sinai, Kole T Roybal, Christoph Wülfing
Cancer Immunology Research|July 10, 2023
Synthesizing a Smarter CAR T Cell: Advanced Engineering of T-cell ImmunotherapiesIowis Zhu, Dan I Piraner, Kole T Roybal
Immunological Reviews|July 26, 2023
Toward the clinical development of synthetic immunity to cancerJulie M Garcia, Cassandra E Burnett, Kole T Roybal
The Journal of Experimental Medicine|June 27, 2022
Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansionAvishai Shemesh, Harry Pickering, Kole T Roybal, et al.
Current Opinion in Immunology|May 10, 2019
NextGen cell-based immunotherapies in cancer and other immune disordersCamillia S Azimi, Qizhi Tang, Kole T Roybal, et al.
Immunological Reviews|October 15, 2013
The actin-driven spatiotemporal organization of T-cell signaling at the system scaleKole T Roybal, Parisa Sinai, Paul Verkade, et al.
Current Opinion in Immunology|July 29, 2015
Synthetic biology approaches to engineer T cellsChia-Yung Wu, Levi J Rupp, Kole T Roybal, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Science Signaling|July 29, 2010
Inhibiting the inhibitor of the inhibitor: blocking PKC-theta to enhance regulatory T cell functionKole T Roybal, Christoph Wülfing
Trends in Cancer|November 11, 2019
Paving New Roads for CARsAxel Hyrenius-Wittsten, Kole T Roybal
Annual Review of Immunology|April 28, 2017
Synthetic Immunology: Hacking Immune Cells to Expand Their Therapeutic CapabilitiesKole T Roybal, Wendell A Lim
Communicative & Integrative Biology|February 19, 2011
Tentative and transient natural killer cell polarization balances the requirements for discriminatory recognition and cytolytic efficacyParisa Sinai, Kole T Roybal, Christoph Wülfing
Cancer Immunology Research|July 10, 2023
Synthesizing a Smarter CAR T Cell: Advanced Engineering of T-cell ImmunotherapiesIowis Zhu, Dan I Piraner, Kole T Roybal
Immunological Reviews|July 26, 2023
Toward the clinical development of synthetic immunity to cancerJulie M Garcia, Cassandra E Burnett, Kole T Roybal
The Journal of Experimental Medicine|June 27, 2022
Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansionAvishai Shemesh, Harry Pickering, Kole T Roybal, et al.
Current Opinion in Immunology|May 10, 2019
NextGen cell-based immunotherapies in cancer and other immune disordersCamillia S Azimi, Qizhi Tang, Kole T Roybal, et al.
Immunological Reviews|October 15, 2013
The actin-driven spatiotemporal organization of T-cell signaling at the system scaleKole T Roybal, Parisa Sinai, Paul Verkade, et al.
Current Opinion in Immunology|July 29, 2015
Synthetic biology approaches to engineer T cellsChia-Yung Wu, Levi J Rupp, Kole T Roybal, et al.
Pageof 5